• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mineralys Therapeutics, Inc. - Common Stock (NQ:MLYS)

    35.55 +0.05 (+0.13%)
    Streaming Delayed Price Updated: 10:25 AM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 120,776
    Open 35.42
    Bid (Size) 35.46 (100)
    Ask (Size) 35.63 (100)
    Prev. Close 35.50
    Today's Range 35.01 - 35.67
    52wk Range 8.241 - 47.65
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗
    When a clinical-stage biotech is sitting on nearly $600 million in cash and lining up an FDA filing, sharp investors stop arguing about the past rally and start debating what comes next. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys ↗
    One small fund’s high-conviction move offers a window into how specialists are navigating 2025’s biotech rally. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +190.2%
    +190.2%
    1 Month
    -12.8%
    -12.8%
    3 Month
    -6.3%
    -6.3%
    6 Month
    +159.5%
    +159.5%
    1 Year
    +183.9%
    +183.9%

    More News

    Read More
    News headline image
    MINERALYS THERAPEUTICS INC (NASDAQ:MLYS) Beats Q3 2025 EPS Estimates and Advances Key Drug Candidate ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Preview For Mineralys Therapeutics ↗
    Via Benzinga
    News headline image
    Uncovering Potential: Mineralys Therapeutics's Earnings Preview ↗
    Via Benzinga
    News headline image
    These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing? ↗
    Via The Motley Fool
    News headline image
    It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps ↗
    Via The Motley Fool
    Topics Economy Stocks
    News headline image
    These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts ↗
    Via The Motley Fool
    News headline image
    Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Here are the top movers in Tuesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Nasdaq Down 1%; Signet Jewelers Earnings Top Views ↗
    Via Benzinga
    News headline image
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results ↗
    Via Investor's Business Daily
    News headline image
    Nasdaq 100, S&P 500 Hit New All-Time Highs, Airlines Jump: What's Moving Markets Tuesday? ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    Earnings Scheduled For August 12, 2025 ↗
    Via Benzinga
    News headline image
    Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps ↗
    Via Benzinga
    News headline image
    This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is Mineralys Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Mineralys Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Mineralys Therapeutics, Inc. - Common Stock trade on?
    Mineralys Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Mineralys Therapeutics, Inc. - Common Stock?
    The ticker symbol for Mineralys Therapeutics, Inc. - Common Stock is MLYS on the Nasdaq Stock Market
    What is the current price of Mineralys Therapeutics, Inc. - Common Stock?
    The current price of Mineralys Therapeutics, Inc. - Common Stock is 35.55
    When was Mineralys Therapeutics, Inc. - Common Stock last traded?
    The last trade of Mineralys Therapeutics, Inc. - Common Stock was at 12/31/25 10:25 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.